Tampa, FL, United States of America

Susan Kay Hoiseth


 

 

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 141(Granted Patents)


Location History:

  • Montebello, NY (US) (2009 - 2017)
  • Tampa, FL (US) (2017 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Susan Kay Hoiseth: Innovator in Immunological Research

Introduction

Susan Kay Hoiseth is a prominent inventor based in Tampa, Florida, known for her significant contributions to immunological research. With a remarkable portfolio of 11 patents, her work primarily focuses on the development of immunogenic compositions and novel methods targeting pathogens, particularly concerning serogroup B polypeptides.

Latest Patents

Among her latest inventions, one noteworthy patent relates to a non-lipidated and non-pyruvylated serogroup B polypeptide. This innovation includes methods of use intended to enhance immunogenic responses. Additionally, she has developed an immunogenic composition featuring an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from serogroup B, combined with conjugated capsular saccharides from a meningococcal serogroup. These inventions are pivotal as they aim to elicit bactericidal immune responses against specific pathogens, showcasing her commitment to advancing medical research.

Career Highlights

Susan has had a distinguished career, having worked with leading pharmaceutical companies like Pfizer Corporation and Wyeth. Her tenure at these organizations has been marked by substantial contributions to vaccine development and immunology, shaping her reputation as a key player in the field.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues, including Annaliesa Sybil Anderson and Kathrin Ute Jansen. These partnerships highlight her ability to work effectively within interdisciplinary teams, collectively pushing the boundaries of scientific knowledge and innovation.

Conclusion

Susan Kay Hoiseth's innovative spirit and dedication to improving immunological outcomes have resulted in a significant body of work that continues to influence the landscape of vaccine research. Her advancements pave the way for new treatments and preventive measures against infectious diseases, securing her position as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…